Aditxt Management

Management criteria checks 3/4

Aditxt's CEO is Amro Albanna, appointed in Jan 2017, has a tenure of 7.17 years. total yearly compensation is $519.23K, comprised of 83.2% salary and 16.8% bonuses, including company stock and options. directly owns 0.51% of the company’s shares, worth $31.66K. The average tenure of the management team and the board of directors is 3.2 years and 5.3 years respectively.

Key information

Amro Albanna

Chief executive officer

US$519.2k

Total compensation

CEO salary percentage83.2%
CEO tenure7.2yrs
CEO ownership0.5%
Management average tenure3.2yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

Aditxt gains on regaining compliance with Nasdaq listing requirements

Sep 29

Aditxt climbs 32% postmarket after completing 1-for-50 reverse stock split

Sep 13

Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidate

Jul 08

Aditxt adds Lauren Chung to board of directors

Jun 18

Aditxt, Todos Medical in distribution pact for for COVID-19 immune monitoring

Dec 14

We Think ADiTx Therapeutics (NASDAQ:ADTX) Can Afford To Drive Business Growth

Nov 23
We Think ADiTx Therapeutics (NASDAQ:ADTX) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Amro Albanna's remuneration changed compared to Aditxt's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$30m

Jun 30 2023n/an/a

-US$27m

Mar 31 2023n/an/a

-US$28m

Dec 31 2022US$500kUS$500k

-US$28m

Sep 30 2022n/an/a

-US$43m

Jun 30 2022n/an/a

-US$46m

Mar 31 2022n/an/a

-US$46m

Dec 31 2021US$2mUS$280k

-US$46m

Sep 30 2021n/an/a

-US$27m

Jun 30 2021n/an/a

-US$20m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$252kUS$252k

-US$9m

Sep 30 2020n/an/a

-US$5m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$6m

Dec 31 2019US$2mUS$252k

-US$6m

Sep 30 2019n/an/a

-US$5m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019n/an/a

-US$5m

Dec 31 2018US$180kUS$180k

-US$6m

Dec 31 2017US$198kUS$51k

-US$852k

Compensation vs Market: Amro's total compensation ($USD519.23K) is about average for companies of similar size in the US market ($USD661.05K).

Compensation vs Earnings: Amro's compensation has increased whilst the company is unprofitable.


CEO

Amro Albanna (53 yo)

7.2yrs

Tenure

US$519,233

Compensation

Mr. Amro A. Albanna has been Chief Executive Officer and a Director of Aditxt, Inc. (formerly known as ADiTx Therapeutics, Inc.) since 2017 and serves as its Chairman of the Board and served as its Preside...


Leadership Team

NamePositionTenureCompensationOwnership
Amro Albanna
Co-Founder7.2yrsUS$519.23k0.51%
$ 31.7k
Shahrokh Shabahang
Co-Founder7.2yrsUS$358.84k0.39%
$ 24.1k
Thomas Farley
Chief Financial Officer2.5yrsUS$381.45k0.25%
$ 15.1k
Corinne Pankovcin
Chief Commercialization Officer1.9yrsUS$390.33k0.25%
$ 15.6k
Rowena Albanna
Chief Operating Officer3.7yrsno data0.25%
$ 15.5k
Jennifer Lee
Director of Human Resources3.2yrsno datano data
Dolly Tyan
Senior Vice President of Clinical Development – Transplantation3.2yrsno datano data
Ge Chen
Senior Vice President of Preclinical Research & Discovery2.2yrsno datano data

3.2yrs

Average Tenure

57yo

Average Age

Experienced Management: ADTX's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Amro Albanna
Co-Founder7.2yrsUS$519.23k0.51%
$ 31.7k
Shahrokh Shabahang
Co-Founder7.2yrsUS$358.84k0.39%
$ 24.1k
Jeffrey Runge
Independent Director3.7yrsUS$15.00k0.025%
$ 1.5k
Charles Athle Nelson
Independent Directorless than a yearno data0.037%
$ 2.3k
Brian Brady
Independent Director5.3yrsUS$15.00k0.025%
$ 1.5k

5.3yrs

Average Tenure

60yo

Average Age

Experienced Board: ADTX's board of directors are considered experienced (5.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.